Logo
Title
Regulatory Rapporteur October 2017
Summary
In This Issue FOCUS - Early access to medicines PLUS Considerations for biologics marketing applications Interview: In conversation with the MHRA’s Dr Ian Hudson
DocumentAccess
Regulatory Rapporteur October 2017MEMBERS
Marketing applications for biopharmaceuticals: Considerations for different jurisdictions – Part 1MEMBERS
Meet the Regulators Interview: Advocating innovation and driving changesMEMBERS
First anniversary of PRIME: Experience so farMEMBERS
Promoting excellence in the regulatory affairs profession: a competency frameworkMEMBERS
Meet the Regulators Interview: A collaborative approach to healthMEMBERS
PRIME emerges from its chrysalisMEMBERS
Editorial: Early patient access at the forefront PUBLIC
Real world experience of PRIME and PIM applications PUBLIC